Comerica Reports Third Quarter 2019 Earnings Results
DALLAS, Oct. 16, 2019 /PRNewswire/ -- Comerica Incorporated (NYSE: CMA) today has reported its third quarter 2019 financial results. The results are available on the Investor Relations section of Comerica's website here. In addition, the financial results and earnings presentation will be furnished on a Form 8-K that will be available on the Securities and Exchange Commission website at www.sec.gov.
As previously announced, Comerica will host a conference call to review the third quarter 2019 financial results. Interested parties may access the call and supplemental materials through the following details:
DATE:
Wednesday, October 16, 2019
TIME:
7 a.m. (Central Time)
PARTICIPANT DIAL-IN:
(800) 309-2262 or (706) 679-5261
(Event ID No. 9596359)
WEBCAST/PRESENTATION:
The live audio webcast, earnings release and earnings presentation will be available on the Investor Relations Presentations and Events page on www.comerica.com.
REPLAY INFORMATION:
A replay (accessible for one year) of the call is expected to be available approximately one hour after the live webcast on the Investor Relations Presentations and Events page on www.comerica.com.
Comerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Business Bank, The Retail Bank, and Wealth Management. Comerica focuses on relationships, and helping people and businesses be successful. In addition to Texas, Comerica Bank locations can be found in Arizona, California, Florida and Michigan, with select businesses operating in several other states, as well as in Canada and Mexico.
CACI International Inc , a leading provider of expertise and technology to government customers, announced results today for its fiscal third quarter ended March 31, 2024.
"CACI's outstanding performance reflects the continued successful execution...
BeiGene, Ltd. , a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024....
Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics.
This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin...
Cadence Design Systems, Inc. and TSMC have extended their longstanding collaboration by announcing a broad range of innovative technology advancements to accelerate design, including developments ranging from 3D-IC and advanced process nodes to...
Arrowhead Pharmaceuticals, Inc. today announced that it will host a webcast and conference call on May 9, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter ended March 31, 2024.
Webcast and Conference Call and...
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced three accepted abstracts at the 2024 American Society of...
